- cafead   Aug 09, 2023 at 10:22: PM
via Meissa Vaccines has reported positive data from a clinical study of the intranasal live attenuated MV-012-968 vaccine against respiratory syncytial virus (RSV) in participants aged between six and 36 months.
article source
article source